Medication Brand Name:

NSativex

 
Active Ingredient:
THC:CBD (delta-9-tetrahydrocannabinol and cannabidiol)
 
DIN(s) in Canada:
02266121
 
francais
Manufacturer/Distributor:
Bayer HealthCare Pharmaceuticals/ Bayer HealthCare Produits pharmaceutiques
 
DrugCoverage Category:
Cancer
 
See Also:
MS


SATIVEX® is an eligible benefit through most private insurance plans and is being reviewed for funding by provincial/ territorial programs and federal plans. Reimbursement through Special Authorization or through Palliative Care Programs may also be available for SATIVEX® through some provincial/ territorial and federal programs. For more detailed information (including reimbursement criteria, guidelines, claim forms) click HERE.

Product Monograph
 
Coverage/Reimbursement by Private Insurance Plans in Canada
SATIVEX® is an eligible benefit for some private insurance plans. Some plans may require special authorization / prior authorization before granting reimbursement.For more detailed information (including reimbursement criteria, guidelines, claim forms) click HERE.
 
Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province Coverage Program / Eligibility Criteria
 
Coverage/Reimbursement by Canadian Federal Plans
Plan Coverage Program / Eligibility Criteria
Public Services Health Care Plan Possible Coverage SATIVEX may be covered by the Public Services Health Care Plan
Non-Insured Health Benefits Under Review SATIVEX is not currently on the NIHB Drug Benefit List, however Exception Drug requests may be submitted for consideration.
Veterans Affairs Canada Under Review SATIVEX is not currently on the Veterans Affairs Canada formulary, however special requests for coverage may be submitted for consideration.
 
Health Canada Drug Product Database Listing